Initial Treatment for Costochondritis
The first-line treatment for costochondritis is a short course of nonsteroidal anti-inflammatory drugs (NSAIDs) for 1-2 weeks, along with temporary rest and application of ice or cool packs to the affected area. 1, 2
Diagnosis and Clinical Features
Costochondritis is characterized by:
- Localized pain and tenderness at the costochondral or chondrosternal junctions
- Pain typically affects the 3rd to 7th ribs
- Pain reproducible with palpation of the affected area
- Absence of swelling, redness, or warmth (distinguishes from infectious causes)
Treatment Algorithm
First-Line Treatment
Non-pharmacological approaches:
Pharmacological treatment:
Second-Line Treatment
For patients who fail to respond to initial treatment:
Local therapy options:
Physical therapy approaches:
For Refractory Cases
- Low-dose colchicine may be considered for severe cases unresponsive to NSAIDs or steroids 6
- Short tapering course of oral corticosteroids for severe inflammation 1
Special Considerations
Elderly Patients and Those with Comorbidities
- Use caution with NSAIDs due to increased risk of adverse effects
- Consider acetaminophen as first-line therapy
- Topical NSAIDs may be safer alternatives 3
Differential Diagnosis
Before treating for costochondritis, rule out serious causes of chest pain:
- Cardiac conditions (especially in patients >35 years or with cardiac risk factors) 2
- Infectious costochondritis (characterized by swelling, redness, purulent discharge) 7
- Other musculoskeletal conditions
Monitoring and Follow-up
- Assess response to treatment within 1-2 weeks
- If symptoms persist beyond 2-3 weeks or worsen, consider further evaluation
- For patients >35 years or with cardiac risk factors, consider ECG and possibly chest radiograph 2
Common Pitfalls to Avoid
- Failing to rule out cardiac causes of chest pain, especially in older adults or those with risk factors
- Prolonged use of NSAIDs without appropriate monitoring for adverse effects
- Overuse of corticosteroids for a condition that is typically self-limiting
- Inadequate patient education about activity modification and expected course of illness
Costochondritis is usually self-limiting, with most cases resolving within weeks to months. Providing reassurance to patients about the benign nature of the condition is an important aspect of management.